Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Marcela Uliano
    Member
    • Apr 2012
    • 19

    #1

    bioinformatics

    Hey guys!

    I was wondering how should I interpret the quality scores coming from results from 454 GS jr cDNA (not paired end) reads?

    I mean, I read a lot that its prhed-like. But as the sequencing techniques from sanger and pyrosequencing are so different from each other, I wonder if its true.

    Could you help me find literature about these quality scores thing and to be able to understand by analyzing my data if the quality of my reads are good or not?

    Im a little confuse about that and havent got to any conclusions so far.

    Thanks a lot!
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    Well they are using the same PHRED logarithmic scoring scale (probability of error), but given the typical error in Roche 454 reads is in homopolymer repeat number this doesn't map well to a per-base quality score.

    Comment

    • Marcela Uliano
      Member
      • Apr 2012
      • 19

      #3
      Thanks maubp

      So the quality valeu coming with the sff file or the one from the fasta format (fna), the .qual are based on PHRED logarithmic scale?

      Comment

      • maubp
        Peter (Biopython etc)
        • Jul 2009
        • 1544

        #4
        The SFF file contains the called bases (which can be turned into a FASTA file) and the associated per-base PHRED quality scores (which can be turned into a QUAL file).

        It might help to change the title of your thread from 'Bioinformatics' to something like 'Interpreting Roche 454 per-base quality scores'.

        Comment

        • Marcela Uliano
          Member
          • Apr 2012
          • 19

          #5
          Thanks a lot maubp!

          Ill do that. But you, pretty much, have already helped me to solve my doubt!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          17 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Working...